Crossmark

Cluster randomised trials of prescribing policy: an ethical approach to generating drug safety evidence? A discussion of the ethical application of a new research method

Crossref DOI link: https://doi.org/10.1186/s13063-020-04357-4

Published Online: 2020-06-05

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Rogers, Amy https://orcid.org/0000-0001-5207-7032
Craig, Gillian

Flynn, Angela

Mackenzie, Isla

MacDonald, Thomas

Doney, Alexander
Funding

Funding for this research was provided by:

Chief Scientist Office (CGA/18/36)
License Information

Text and Data Mining valid from 2020-06-05

Version of Record valid from 2020-06-05
More Information

Article History

Received: 30 September 2019

Accepted: 28 April 2020

First Online: 5 June 2020

Ethics approval and consent to participate

: All pilot study participants were informed of the study taking place and were given the option to opt out of medication switching. The opt-out consent process was approved by East of Scotland Research Ethics Service (EoRES), REC reference 17/ES/0016.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below